Author:
Fujii Kenichi,Carlier Stéphane G.,Mintz Gary S.,Yang Yi-ming,Moussa Issam,Weisz Giora,Dangas George,Mehran Roxana,Lansky Alexandra J.,Kreps Edward M.,Collins Michael,Stone Gregg W.,Moses Jeffrey W.,Leon Martin B.
Subject
Cardiology and Cardiovascular Medicine
Reference13 articles.
1. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study;Sousa;Circulation,2001
2. , on behalf of the RAVEL Study Group. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions;Morice;A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med,2002
3. , on behalf of the SIRIUS Investigators;Moses;N Engl J Med,2003
4. U.S. Food and Drug Administration. FDA Advises Physicians of Adverse Events Associated with Cordis Cypher Coronary Stents. U.S. Food and Drug Administration Public Health Web Notification. Available at: http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01257.html. Accessed October 29, 2003.
5. Stent thrombosis after successful sirolimus-eluting stent implantation;Jeremias;Circulation,2004
Cited by
665 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献